Symptomatic Carotid Arteries: Early or Late Emergency Revascularization?

Carotid endarterectomy continues to be the safest technique for emergency revascularization. However, 48 hours after index event, different strategy outcomes will become comparable. 

Carótidas sintomáticas: ¿revascularización urgente, precoz o retardada?

Multiple advances in device development have brought promising results for carotid revascularization patients with symptomatic stenosis. Regardless these developments, optimal revascularization timing after index event remains unclear

This study included patients with symptomatic carotid stenosis undergoing transcarotid artery revascularization (TCAR), transfemoral carotid stenting (TFCAS), or carotid endarterectomy (CEA) at different times after index event. 

Procedures were regarded as urgent (0 to 2 days after last event), early (3 to 14 days) or late (15 to 180 days).

Primary end point was inhospital death or stroke. Secondary end point added transient ischemic event. 

The study included 18,643 symptomatic revascularizations: 10.8% were urgent, 39.8% were early, and the remaining half was late.


Read also:  TICO: Age Impacts the Effect of Antiplatelet Monotherapy.


Patients undergoing TFCAS showed the highest rate of stroke and death at all timing cohorts. 

Among urgent cases, CAE had 4% events vs 6.9% for TFCAS and 6.5% for TCAR (p=0.018). These differences tended to level off the later patients were treated. 

When adjusting for risk, OR resulted similar between patients undergoing CAE and TCAR. 

Conclusion

CAE continues to be the safest revascularization approach for emergency cases. TCAR and CAE seem similar after 48 hours. 

Original Title: In-Hospital Outcomes of Urgent, Early, or Late Revascularization for Symptomatic Carotid Artery Stenosis.

Reference: Christina L. Cui et al. J Am Heart Assoc. 2021 Dec 21;10(24):e022700. doi: 10.1161/JAHA.121.022700.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

PERFORMANCE II Trial: Safety and Efficacy of the New NeuroGuard Carotid Stent System

The percutaneous treatment of carotid artery disease through stenting (CAS) for the prevention of cerebrovascular disease has proven to be an effective alternative compared...

Trends in the Treatment of Critical Lower Limb Ischemia

Approximately 25% of patients with critical lower limb ischemia (CLLI) face amputation within the first year after diagnosis (according to statistics from the United...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...